T-Knife is listed on the portfolio pages of Andera Partners (portfolio page) and EQT Partners (portfolio page). Andera Partners and EQT Partners list it as current. Andera Partners has owned T-Knife since 2018, per Andera Partners' portfolio page.
T-knife Therapeutics is a biopharmaceutical company dedicated to developing novel therapeutics to fight cancer.
Source: t-knife.com, read November 2026
T-Knife is a Life Sciences company. Its owner on record, Andera Partners, is a private equity firm. Andera Partners lists 291 companies in the index, 36 of them in Life Sciences. Also backed by EQT Partners.
Andera Partners is a private equity asset management firm that invests in companies and their management to support growth and innovation.
Read the Andera Partners profileEQT AB is a leading Swedish global investment organization that manages a variety of investment funds across several asset classes.
Read the EQT Partners profileT-Knife is listed on the portfolio pages of Andera Partners (portfolio page) and EQT Partners (portfolio page). Andera Partners and EQT Partners list it as current. Andera Partners has owned T-Knife since 2018, per Andera Partners' portfolio page.
T-Knife is in Life Sciences. Classified from the owner's portfolio label.
Andera Partners lists 35 other Life Sciences companies in the index, including Adler Ortho, AgoMab, AM Pharma, Amolyt Pharma and Artios Pharma.
T-Knife's website is https://www.t-knife.com/.
6 of 290 shown
See the full Andera Partners portfolio.
6 of 357 shown
See the full EQT Partners portfolio.
Browse PE-backed companies.
